Ignite Creation Date:
2025-12-25 @ 4:48 AM
Ignite Modification Date:
2026-02-20 @ 5:57 PM
Study NCT ID:
NCT02429518
Status:
COMPLETED
Last Update Posted:
2020-09-04
First Post:
2015-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
Sponsor:
Knight Therapeutics (USA) Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MILT 2127-3
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None